ARADIGM CORP. ARDM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (128)	12/4/2001 11:04:08 AM
From: tuck	Read Replies (1) of 255

Newish (& BLUE HPish) competitor AEGN stumbles: >>NEW YORK, Dec 4 (Reuters) - Aerogen Inc. (NasdaqNM:AEGN - news), a developer of drugs for respiratory disorders, said Tuesday that biotechnology company Chiron Corp. (NasdaqNM:CHIR - news) will no longer help Aerogen develop its Aerodose Tobi inhaled drug for cystic fibrosis. Sunnyvale, California-based Aerogen said it is ``very disappointed'' by Chiron's decision as it will aggressively pursue the development of inhaled products both for commercialization by Aerogen and in collaboration with partners. Aerogen has three products in development for the treatment of respiratory disease. The company will hold a conference call at 11:30 a.m. EST (1630 GMT) to discuss the implications of Chiron's withdrawal from its Aerodose program. Chiron is already in partnership with Inhale Therapeutic Systems Inc. (NasdaqNM:INHL - news) to develop inhaled antibiotics. Aerogen's shares fell 6 cents, or 1.86 percent, to $3.16 in mid-morning trading on Nasdaq.<< Looks like failure was anticipated. snip Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next